335 related articles for article (PubMed ID: 15194406)
1. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
Beilke J; Johnson Z; Kuhl N; Gill RG
Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
[TBL] [Abstract][Full Text] [Related]
2. Both innate and adaptive major histocompatibility complex class I-dependent immunity impair long-term islet xenograft survival.
Ramirez-Victorino F; Beilke JN; Gill RG
Transplant Proc; 2008 Mar; 40(2):557-8. PubMed ID: 18374128
[TBL] [Abstract][Full Text] [Related]
3. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
Gordon EJ; Kelkar V
Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
[TBL] [Abstract][Full Text] [Related]
4. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
[TBL] [Abstract][Full Text] [Related]
5. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
Beilke JN; Kuhl NR; Van Kaer L; Gill RG
Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
[TBL] [Abstract][Full Text] [Related]
6. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
[TBL] [Abstract][Full Text] [Related]
7. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
8. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
10. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
Coulombe M; Yang H; Wolf LA; Gill RG
J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
[TBL] [Abstract][Full Text] [Related]
12. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
13. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
[TBL] [Abstract][Full Text] [Related]
14. Islet allograft rejection is independent of toll-like receptor signaling in mice.
Hutton MJ; Westwell-Roper C; Soukhatcheva G; Plesner A; Dutz JP; Verchere CB
Transplantation; 2009 Nov; 88(9):1075-80. PubMed ID: 19898202
[TBL] [Abstract][Full Text] [Related]
15. Roles of CD4+ and CD8+ cells in islet allo- and xeno-graft rejection.
Gotoh M; Monden M; Yamamoto H; Kawai M; Ichikawa T; Mori T; Uenaka A; Nakayama E
Horm Metab Res Suppl; 1990; 25():173-6. PubMed ID: 1982441
[TBL] [Abstract][Full Text] [Related]
16. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
[No Abstract] [Full Text] [Related]
18. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
19. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
[No Abstract] [Full Text] [Related]
20. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]